Benaree Pratt Wiley Sells 1,600 Shares of CBIZ, Inc. (NYSE:CBZ) Stock

CBIZ, Inc. (NYSE:CBZ) Director Benaree Pratt Wiley sold 1,600 shares of CBIZ stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $26.75, for a total value of $42,800.00. Following the completion of the sale, the director now owns 9,202 shares in the company, valued at $246,153.50. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Benaree Pratt Wiley also recently made the following trade(s):

  • On Friday, November 1st, Benaree Pratt Wiley sold 1,600 shares of CBIZ stock. The shares were sold at an average price of $27.45, for a total value of $43,920.00.
  • On Thursday, October 3rd, Benaree Pratt Wiley sold 1,600 shares of CBIZ stock. The shares were sold at an average price of $23.15, for a total value of $37,040.00.

Shares of CBZ opened at $27.00 on Friday. CBIZ, Inc. has a 1-year low of $18.64 and a 1-year high of $28.13. The company has a current ratio of 1.44, a quick ratio of 1.44 and a debt-to-equity ratio of 0.45. The firm’s 50-day moving average price is $26.26 and its 200-day moving average price is $22.96. The firm has a market capitalization of $1.48 billion, a price-to-earnings ratio of 24.77 and a beta of 0.33.

CBIZ (NYSE:CBZ) last released its quarterly earnings results on Wednesday, October 30th. The business services provider reported $0.32 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.25 by $0.07. CBIZ had a net margin of 7.51% and a return on equity of 11.36%. The company had revenue of $239.79 million during the quarter, compared to the consensus estimate of $234.56 million. During the same period in the prior year, the firm earned $0.24 earnings per share. CBIZ’s revenue was up 6.9% on a year-over-year basis. On average, research analysts forecast that CBIZ, Inc. will post 1.23 EPS for the current fiscal year.

CBZ has been the subject of a number of research analyst reports. ValuEngine lowered CBIZ from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Zacks Investment Research raised shares of CBIZ from a “hold” rating to a “strong-buy” rating and set a $32.00 price objective on the stock in a research report on Thursday, October 31st.

Hedge funds have recently bought and sold shares of the business. Swiss National Bank lifted its stake in shares of CBIZ by 1.4% in the 2nd quarter. Swiss National Bank now owns 97,300 shares of the business services provider’s stock valued at $1,906,000 after purchasing an additional 1,300 shares during the period. DekaBank Deutsche Girozentrale purchased a new position in CBIZ during the second quarter valued at $37,000. JPMorgan Chase & Co. lifted its position in CBIZ by 2.2% during the second quarter. JPMorgan Chase & Co. now owns 425,157 shares of the business services provider’s stock valued at $8,339,000 after buying an additional 9,268 shares during the period. First Mercantile Trust Co. purchased a new position in CBIZ during the third quarter valued at $38,000. Finally, Rice Hall James & Associates LLC boosted its holdings in shares of CBIZ by 15.9% during the 2nd quarter. Rice Hall James & Associates LLC now owns 104,951 shares of the business services provider’s stock valued at $2,056,000 after buying an additional 14,430 shares in the last quarter. Hedge funds and other institutional investors own 88.05% of the company’s stock.

About CBIZ

CBIZ, Inc provides professional business services, products, and solutions that help its clients in managing finances and employees. It offers its services through three groups: Financial Services, Benefits and Insurance Services, and National Practices. The Financial Services group provides accounting and tax, government healthcare consulting, financial advisory, valuation, and risk and advisory services.

Featured Story: What are the risks of holding treasury bonds?

Insider Buying and Selling by Quarter for CBIZ (NYSE:CBZ)

Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.